These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26231735)

  • 1. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.
    Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C
    Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals.
    Song W; Yeh CR; He D; Wang Y; Xie H; Pang ST; Chang LS; Li L; Yeh S
    Oncotarget; 2015 Aug; 6(22):19290-304. PubMed ID: 26079540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
    Guan Z; Li C; Fan J; He D; Li L
    Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Infiltrating Neutrophils Promote Renal Cell Carcinoma (RCC) Proliferation via Modulating Androgen Receptor (AR) → c-Myc Signals.
    Atala A
    J Urol; 2016 Jun; 195(6):1947-9. PubMed ID: 27191115
    [No Abstract]   [Full Text] [Related]  

  • 5. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
    Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
    Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
    Zhai W; Sun Y; Jiang M; Wang M; Gasiewicz TA; Zheng J; Chang C
    Oncogene; 2016 Sep; 35(37):4866-80. PubMed ID: 26973243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.
    Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C
    Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling.
    Yang Z; Xie H; He D; Li L
    Oncotarget; 2016 Jul; 7(28):44478-44491. PubMed ID: 27283897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals.
    Ou Z; Wang Y; Liu L; Li L; Yeh S; Qi L; Chang C
    Oncotarget; 2015 Sep; 6(28):26065-78. PubMed ID: 26305549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
    Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
    Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
    Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
    Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals.
    Xie H; Li L; Zhu G; Dang Q; Ma Z; He D; Chang L; Song W; Chang HC; Krolewski JJ; Nastiuk KL; Yeh S; Chang C
    Oncotarget; 2015 May; 6(14):12326-39. PubMed ID: 25940439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals.
    Lin C; Lin W; Yeh S; Li L; Chang C
    Oncotarget; 2015 Dec; 6(40):43081-9. PubMed ID: 26517808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1.
    Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D
    Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.
    Pak S; Kim W; Kim Y; Song C; Ahn H
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2293-2301. PubMed ID: 31401673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway.
    He D; Li L; Zhu G; Liang L; Guan Z; Chang L; Chen Y; Yeh S; Chang C
    Cancer Res; 2014 Aug; 74(16):4420-30. PubMed ID: 24924778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling.
    Chen Y; Li C; Xie H; Fan Y; Yang Z; Ma J; He D; Li L
    Oncogene; 2017 May; 36(20):2879-2888. PubMed ID: 28114284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo.
    Yang S; Jiang M; Grabowska MM; Li J; Connelly ZM; Zhang J; Hayward SW; Cates JM; Han G; Yu X
    Oncotarget; 2016 Oct; 7(43):70404-70419. PubMed ID: 27611945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.